# Newomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/newomics

- Industry: Medical Devices & Equipment
- Headquarters: Berkeley, US
- Website: www.newomics.com
- Total disclosed funding: $7.8M
- Latest round: Series B (Oct 13, 2020)
- Investors on record: 4

## About

Established in 2018 and based in California, US, Newomics Inc. operates as a biotechnology company that creates and develops multi-omics diagnostic assays for diabetes, Alzheimer's, and other diseases. The company also commercializes innovative and integrative platforms and solutions for precision medicines.

## Funding rounds

- Series B, Oct 13, 2020, $3.9M — MSA Capital, LDV Management, Photon Fund, Berkeley Catalyst Fund
- Series A, Aug 9, 2018, $3.9M — Photon Fund, Berkeley Catalyst Fund

## Investors

- Photon Fund (https://capitalatlas.ai/funds/photon-fund) — Series A, Series B
- Berkeley Catalyst Fund (https://capitalatlas.ai/funds/berkeley-catalyst-fund) — Series A, Series B
- MSA Capital (https://capitalatlas.ai/funds/msa-capital) — Series B
- LDV Management (https://capitalatlas.ai/funds/ldv-management) — Series B